cyclopentane has been researched along with Angiogenesis, Pathologic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Dongmin, C; Fei, L; Huimei, H | 1 |
| Buachan, P; Namsa-Aid, M; Peng, C; Sung, HK; Sweeney, G; Tanechpongtamb, W | 1 |
| Li, H; Sun, Y; Tan, M | 1 |
| Chen, P; Cheng, H; Chu, YW; Hoffman, RM; Hua, ZC; Jeong, LS; Jia, LJ; Jiang, YN; Lee, HW; Li, LH; Qi, H; Wang, K; Wang, P; Wang, R; Wu, JF; Yang, M; Yao, WT; Ying, HQ; Yu, GY; Yu, J; Yu, XJ | 1 |
| Jia, L; Jiang, Y | 1 |
| Hassan, NM; Hu, GF; Ibaragi, S; Kishimoto, K; Mandai, H; Okui, T; Omori, K; Sasaki, A; Shibata, A; Shimo, T; Suga, S; Takashiba, S; Tsumura, T | 1 |
| Chen, Z; Du, J; Jiang, G; Liang, S; Liu, Q; Su, Q; Wang, H; Wei, W; Zhou, Y | 1 |
| Nisha, VM; Preetha Rani, MR; Priyanka, A; Raghu, KG; Shyni, GL; Sindhu, G | 1 |
| Huang, K; Li, D; Pu, J; Qi, M; Tong, L; Tong, Q; Xiang, X; Zheng, L | 1 |
1 review(s) available for cyclopentane and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication.
Topics: Antineoplastic Agents; Cyclopentanes; Humans; Macrophages; NEDD8 Protein; Neoplasms; Neovascularization, Pathologic; Pyrimidines; Ubiquitins | 2015 |
8 other study(ies) available for cyclopentane and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Pivalopril improves anti-cancer efficiency of cDDP in breast cancer through inhibiting proliferation, angiogenesis and metastasis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Cyclopentanes; Female; Humans; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic | 2020 |
Inhibitory effects of terrein on lung cancer cell metastasis and angiogenesis.
Topics: A549 Cells; Animals; Aspergillus; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Movement; Chlorocebus aethiops; Cyclopentanes; Humans; Lung Neoplasms; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vero Cells | 2021 |
Endothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis.
Topics: Animals; Carrier Proteins; Cell Movement; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Cyclopentanes; Embryo Loss; Endothelial Cells; Gene Deletion; Gene Knockdown Techniques; Melanoma, Experimental; Mice, Knockout; NEDD8 Protein; Neovascularization, Pathologic; Pyrimidines; Ubiquitin-Protein Ligases; Ubiquitins | 2014 |
Suppression of tumor angiogenesis by targeting the protein neddylation pathway.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Carrier Proteins; Cell Cycle Checkpoints; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Cullin Proteins; Cyclopentanes; DNA Damage; Dose-Response Relationship, Drug; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Nude; NEDD8 Protein; Neovascularization, Pathologic; Neovascularization, Physiologic; Pancreatic Neoplasms; Protein Processing, Post-Translational; Pyrimidines; Rats; Rats, Sprague-Dawley; rhoA GTP-Binding Protein; RNA Interference; Time Factors; Tissue Culture Techniques; Transfection; Tumor Burden; Ubiquitin-Activating Enzymes; Ubiquitins; Xenograft Model Antitumor Assays | 2014 |
Synthetic Terrein Inhibits Progression of Head and Neck Cancer by Suppressing Angiogenin Production.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Disease Progression; Head and Neck Neoplasms; Human Umbilical Vein Endothelial Cells; Humans; Neovascularization, Pathologic; Ribonuclease, Pancreatic | 2016 |
Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
Topics: Animals; Antibodies; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Movement; Cyclopentanes; Dose-Response Relationship, Drug; Female; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Interleukin-6; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neovascularization, Pathologic; Neovascularization, Physiologic; NF-kappa B; Phosphorylation; Promoter Regions, Genetic; Quinolines; Receptors, Estrogen; Receptors, G-Protein-Coupled; Signal Transduction; STAT3 Transcription Factor; Time Factors; Triple Negative Breast Neoplasms; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2017 |
Bilobalide abates inflammation, insulin resistance and secretion of angiogenic factors induced by hypoxia in 3T3-L1 adipocytes by controlling NF-κB and JNK activation.
Topics: Adipocytes; Anti-Inflammatory Agents; Cell Line; Cyclopentanes; Furans; Ginkgolides; Humans; Hypoxia; Inflammation; Insulin Receptor Substrate Proteins; Insulin Resistance; MAP Kinase Kinase 4; Neovascularization, Pathologic; NF-kappa B; Obesity; Signal Transduction; Transcriptional Activation | 2017 |
Methyl jasmonate abolishes the migration, invasion and angiogenesis of gastric cancer cells through down-regulation of matrix metalloproteinase 14.
Topics: Acetates; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Binding Sites; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Chromatin Immunoprecipitation; Cyclopentanes; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 14; Neoplasm Invasiveness; Neovascularization, Pathologic; Oxylipins; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Sp1 Transcription Factor; Stomach Neoplasms; Time Factors; Transfection; Vascular Endothelial Growth Factor A | 2013 |